source
- AstraZeneca taps Oracle to help improve recruitment for clinical trialsAstraZeneca has turned to data giant Oracle as the U.K.-based Big Pharma works on one of the eternal problems of drug development—improving patient recruitment.Fierce Biotech · 4h ago↗ source
- Disc spins past FDA rejection with ‘overwhelmingly positive’ phase 3 data for rare disease drugA phase 3 trial of Disc Medicine’s bitopertin has hit both co-primary endpoints and all secondary endpoints, positioning the biotech to refile for approval of the once-rejected rare disease drug ca…